Genetically engineered mesenchymal stem cells using viral vectors: a new frontier in anti-angiogenic therapy
Mesenchymal stem cells (MSCs) are adult stem cells that possess the remarkable ability to self-renew and differentiate into various cell lineages. Due to their regenerative potential, MSCs have emerged as the most commonly used stem cell type in clinical applications. Angiogenesis, the formation of...
Main Authors: | Choy, Ewa Yee Wa, Choy, Ker Woon, Woon, Kai Siong, Muhammad Aidil Wafi, Then, Kong Yong, Then, Khong Lek |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2024
|
Online Access: | http://journalarticle.ukm.my/23598/1/SMS%206.pdf |
Similar Items
-
Viral-Vector-Delivered Anti-Angiogenic Therapies to the Eye
by: Sanna Koponen, et al.
Published: (2021-02-01) -
Adeno-associated viral vectors at the frontier between tolerance and immunity
by: Federico eMingozzi, et al.
Published: (2015-03-01) -
Potential angiogenic, immunomodulatory, and antifibrotic effects of mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis
by: Kelin Zhao, et al.
Published: (2023-05-01) -
Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia
by: Eireen Tang, et al.
Published: (2022-10-01) -
The Angiogenic Potential of Mesenchymal Stem Cells from the Hair Follicle Outer Root Sheath
by: Vuk Savkovic, et al.
Published: (2021-02-01)